CD44 is a cell surface receptor that is overexpressed in breast cancer, and targeting this receptor could facilitate intracellular uptake of nanoparticles, thereby increasing drug concentrations in cancer cells through CD44 receptor-mediated endocytosis [45,46,47,48,49,50,51]. The gene discussed is CD44; the disease is breast cancer.